Please ensure Javascript is enabled for purposes of website accessibility

The Stocks You Need to Buy Now

By Tim Hanson – Updated Nov 9, 2016 at 9:28PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Do you know what you're missing?

How much time are you going to spend thinking about the next stock you buy? If you're like most Americans, the answer is "not much." According to research from ING, "the average American spends more time researching a new refrigerator than they do stocks."

Now, we all need a good place to keep our beer cold, but that's ludicrous ... and it gets worse.

A recent Bankrate.com survey revealed that just 16% of Americans invest according to an asset allocation plan. This means that 84% of us are blindly buying stocks without any regard for what we may or may not already own or hoping someone else does it right for us!

Why this is bad
The consequence of this is that individual investors get overexposed to certain "hot" sectors. Think back to 2000. Four of the five most widely owned stocks were tied to the Internet bubble -- AT&T (NYSE: T), AOL (NYSE: AOL), Lucent (NYSE: ALU), and Verizon (NYSE: VZ). As a result, when the Internet bubble collapsed, investors who owned all of these popular stocks got hit harder than they would have had they owned some of the materials and emerging markets stocks that survived the 2000-01 downturn fairly well.

This is why it's important to invest according to an asset allocation plan. Not only will it protect your portfolio from short-term volatility in a specific company, country, sector, or asset class, but it will help you make more money over the long term as a result.

How to think about asset allocation in 2010
We recently asked our members at Motley Fool Global Gains to review their asset allocation and let us know what they need to get exposure to in 2010. To help them make that determination, we updated our global asset allocation guidelines. While every individual needs an asset allocation plan tailored specifically to his or her situation, here's how our Global Gains guidelines break down for the typical "aggressive" investor.

  • We want 85% if your investable assets in stocks and 15% in bonds.
  • We want 60% invested within the United States and 40% internationally.
  • Within that international exposure, we want 75% invested in emerging markets and 25% in developed markets.

Some will look at those guidelines and call them overly aggressive. We disagree. They're based on our market outlook and valuation analysis and synthesize the work of top investment minds such as Warren Buffett, Mohammed el-Erian, and Jeremy Siegel. As I've written before, the dollar is doomed, and the top markets over the next decade will be currently emerging markets such as China, India, and Brazil.

Is your asset allocation up to snuff?
Unfortunately, Americans today are dangerously underexposed to the rest of the world's markets, with one survey showing that U.S. investors have just 6% of their savings invested outside of the United States. Even our Global Gains members, a very worldly group, are finding that their portfolios aren't yet sufficiently exposed to Africa and Latin America.

What are you missing? I encourage you to find out.

Put your portfolio to the test
When it comes to calculating your foreign exposure, the key is not to look at where the companies you own are headquartered, but rather where they do business. Take Teva Pharmaceutical (Nasdaq: TEVA), for example. Although the company is headquartered in Israel and could be classed as an emerging markets stock as a result, it actually makes more than 80% of its sales in North America and Europe. Thus, for asset allocation purposes, Teva is better considered a developed market stock, or even a U.S. stock.

Similarly, although we all think of Microsoft (Nasdaq: MSFT) and McDonald's (NYSE: MCD) as being "American," Microsoft now makes nearly 50% of its sales outside of the United States and McDonald's makes more than 60% of its sales in other countries. Therefore, when it comes to asset allocation, both of these stocks provide more foreign exposure than you might have expected.

Now consider the stocks in your own portfolio. Do any of them offer foreign exposure? Do you own any companies that have made doing business in fast-growing China or Brazil an important part of their strategy.

If the answers to these questions are "no," then stocks that do possess these traits are the stocks you need to buy now.

In sum
With an asset allocation plan and additional foreign exposure, your portfolio will be better positioned to profit over the next decade. If you need some help putting those things in place, come join us at Motley Fool Global Gains, where you can find a variety of asset allocation resources, including our updated asset allocation report, as well as dozens of market-beating international stock recommendations.

Click here for more information.

Tim Hanson is co-advisor of Motley Fool Global Gains and also needs more exposure to Africa. He does not own shares of any company mentioned. Microsoft is a Motley Fool Inside Value recommendation. Motley Fool Options recommended a diagonal call on Microsoft. You don't need to read the Fool's disclosure policy now, but you can peruse it at your leisure.

None

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

McDonald's Corporation Stock Quote
McDonald's Corporation
MCD
$243.76 (-0.89%) $-2.19
Microsoft Corporation Stock Quote
Microsoft Corporation
MSFT
$237.45 (-0.20%) $0.47
Verizon Communications Inc. Stock Quote
Verizon Communications Inc.
VZ
$38.93 (-1.49%) $0.59
AT&T Inc. Stock Quote
AT&T Inc.
T
$15.67 (-2.12%) $0.34
Teva Pharmaceutical Industries Limited Stock Quote
Teva Pharmaceutical Industries Limited
TEVA
$7.69 (-2.66%) $0.21

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.